Secondary Metabolites from Hericium erinaceus and Their Anti-Inflammatory Activities

• Main Authors: Tang, L. (Author), Xie, G. (Author), Xie, L. (Author), Xie, Y. (Author)
• Format: Article
• Language: English
• Published: MDPI 2022
• Subjects: Agaricales; animal; Animals; anti-inflammatory activity; antiinflammatory agent; Anti-Inflammatory Agents; chemistry; Hericium; Hericium erinaceus; interleukin 6; Interleukin-6; isolation and structural elucidation; Mice; mouse; secondary metabolites; tumor necrosis factor; Tumor Necrosis Factor-alpha
• Online Access: View Fulltext in Publisher

 Hericium erinaceus, a culinary and medicinal mushroom, is widely consumed in Asian countries. Chemical investigation on the fruiting bodies of Hericium erinaceus led to the isolation of one new ergostane-type sterol fatty acid ester, erinarol K (1); and eleven known compounds: 5α,8α-epidioxyergosta-6,22-dien-3β-yl linoleate (2); ethyl linoleate (3); linoleic acid (4); hericene A (5); hericene D (6); hericene E (7); ergosta-4,6,8(14),22-tetraen-3-one (8); hericenone F (9); ergosterol (10); ergosterol peroxide (11); 3β,5α,6α,22E-ergosta-7,22-diene-3,5,6-triol 6-oleate (12). The chemical structures of the compounds were determined by 1D and 2D NMR (nuclear magnetic resonance) spectroscopy, mass spectra, etc. Anti-inflammatory effects of the isolated aromatic compounds (5–7, 9) were evaluated in terms of inhibition of pro-inflammatory mediator (TNF-α, IL-6 and NO) production in lipopolysaccharide (LPS)-stimulated murine RAW 264.7 macrophage cells. The results showed that compounds 5 and 9 exhibited moderate activity against TNF-α (IC50: 78.50 µM and 62.46 µM), IL-6 (IC50: 56.33 µM and 48.50 µM) and NO (IC50: 87.31 µM and 76.16 µM) secretion. These results supply new information about the secondary metabolites of Hericium erinaceus and their anti-inflammatory effects. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.